Indication

Solar lentigines

Solar lentigines are common, benign cutaneous hyperpigmentations that arise from chronic exposure to ultraviolet radiation, representing a hallmark of photoaging. Read more about Solar lentigines

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common Solar lentigines therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Solar lentigines preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Solar lentigines.

Solar lentigines are common, benign cutaneous hyperpigmentations that arise from chronic exposure to ultraviolet radiation, representing a hallmark of photoaging.

Typically affecting fair-skinned adults and older populations, these lesions most frequently develop on chronically sun-exposed areas such as the face, dorsum of the hands, forearms, and upper trunk.

Clinically, they present as well-circumscribed, asymptomatic, light-brown to dark-brown macules or small patches that persist independently of seasonal sun variations.

Pathophysiologically, they are characterized by epidermal hyperplasia, elongation of rete ridges, localized proliferation of non-atypical melanocytes, and increased melanin deposition within basal keratinocytes.

Personalize your experience

Follow Solar lentigines and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it